Sat.Feb 04, 2023 - Fri.Feb 10, 2023

article thumbnail

Digital Therapies Poised for Breakthrough in Migraine Treatment

Drug Topics

The number of digital therapeutics available for migraine is likely to expand.

503
503
article thumbnail

3 ways the FDA’s restructuring plan could impact pharma

PharmaVoice

FDA’s food program is in for a major overhaul — here’s why pharma should pay attention.

FDA 243
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

4 Attributes of a Great Pharmacy Technician

Pharmacy Tech Scholar

What Makes a Great Pharmacy Technician? Our students commonly ask us for tips on getting a job after completing our PTCB-recognized education program. Being marketable… The post 4 Attributes of a Great Pharmacy Technician appeared first on Pharmacy Tech Scholar.

PTCB 221
article thumbnail

Do masks really protect against COVID-19? Meta-analysis authors want to see more evidence

Fierce Healthcare

Do masks really protect against COVID-19?

142
142
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Vitamin D Use Connected to Reduced Risk of Diabetes in Adults with Prediabetes

Drug Topics

According to adjusted analyses, vitamin D reduced the risk of diabetes by 15% with a 3-year absolute risk reduction of 3.3%.

503
503
article thumbnail

Woman of the Week: KaliVir Immunotherapeutics’ Helena Chaye

PharmaVoice

The triple threat CEO — scientist, lawyer and biotech pro — thinks she’s discovered a key to curing a wide range of cancers.

239
239

More Trending

article thumbnail

Which payer raked in the most cash last year? The answer likely won't surprise you

Fierce Healthcare

Which payer raked in the most cash last year?

130
130
article thumbnail

Is ChatGPT Healthcare's Next Big Thing?

Drug Topics

Artificial intelligence has the potential to revolutionize and improve medicine. However, in order for widespread implementation, certain challenges and obstacles must first be overcome.

503
503
article thumbnail

United by inequity: The healthcare disparities plaguing rare disease patients and Black Americans

PharmaVoice

Guided by her personal experiences, Tamar Thompson is aiming to improve rare disease care through her advocacy work at Alexion, AstraZeneca Rare Disease.

211
211
article thumbnail

Tracking the bird flu, experts see a familiar threat — and a virus whose course is hard to predict

STAT

Veteran influenza epidemiologist Keiji Fukuda remembers vividly when he first became fearful that a virulent bird flu virus, H5N1, might be on the verge of triggering a devastating pandemic. The virus, seemingly out of nowhere, did something bird flu viruses were thought not to be able to do. It infected 18 people, killing six of them. That happened in 1997, in Hong Kong.

132
132
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Black History Month: Pharmacy Trailblazers

Pharmacy Is Right For Me

February marks Black History Month in the United States. We want to take this opportunity to recognize some Black pharmacists who have made significant contributions to the pharmacy field. James McCune Smith James McCune Smith was born into slavery in 1813. He earned his medical degree from Glasgow University. He is recognized as the first African American to earn a medical degree, the first to be published in American medical journals, as well as the first African American to own and operate a

article thumbnail

State of the Union: Drug Prices, Affordable Care, and Cancer A Priority for Biden Administration

Drug Topics

President Biden's 2023 State of the Union address highlighted some key areas of health care in which he hopes to make progress.

469
469
article thumbnail

Why are there gaps in mental healthcare? Often it’s flawed trial methodology

PharmaVoice

Sunovion Pharmaceuticals has developed a more precise way to track symptoms that could be broadly adopted across the industry.

147
147
article thumbnail

Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics

Fierce Pharma

Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics fkansteiner Tue, 02/07/2023 - 10:08

124
124
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

CVS Health to acquire Oak Street Health for $10.6B

Drug Store News

CVS Health will acquire Oak Street Health in an all-cash transaction at $39 per share, representing an enterprise value of approximately $10.6 billion.

120
120
article thumbnail

Assessing Biologic Medications for Effective Management of Severe Asthma in Adults

Drug Topics

The use of biomarker profiles to guide asthma treatment decisions have not been well-studied.

467
467
article thumbnail

Rocket Pharmaceuticals is ready for liftoff in the rare disease space

PharmaVoice

With two rare disease products on the launch pad for FDA submission in 2023 and a growing pipeline, Rocket is fueled for its next era of growth.

FDA 147
article thumbnail

Scottish biotech aims to cure common cold

Pharmafile

Scottish biotech company ScotBio has announced that it has seen “promising initial results” from its attempts to extract a cure for the common cold from algae. The Livingston-based company is assessing how waste molecules from spirulina, an algae often consumed as a superfood, could be used as a cure for the common cold, COVID-19 and various other viruses.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Five potential EU regulatory changes impacting the life sciences industry in 2023

European Pharmaceutical Review

A wave of important legislative changes is anticipated in the EU in 2023 making this year one of the biggest for the EU regulatory landscape governing the life sciences industry in recent times. Changes have been spurred by the COVID-19 pandemic, which emphasised the need to urgently modernise outdated EU pharmaceutical law and revise regulatory ambitions in the MedTech sector.

Packaging 117
article thumbnail

Can Patient-Centered Prescription Labels Increase Medication Adherence?

Drug Topics

Researchers evaluated how changes in USP labeling standards have affected adherence across multiple classes of drugs.

Labelling 467
article thumbnail

Entact Bio’s CEO is leading the company out of stealth and into a new age of protein enhancement

PharmaVoice

Victoria Richon’s latest venture is in the burgeoning field of protein-regulated drugs that could target a range of diseases.

147
147
article thumbnail

How the current economic downturn impacts healthcare funding and investor strategy

Fierce Healthcare

How the current economic downturn impacts healthcare funding and investor strategy agliadkovskaya Fri, 02/10/2023 - 10:37

116
116
article thumbnail

STAT+: Bayer, facing investor ire, appoints an outsider CEO

STAT

Bayer named former Roche executive Bill Anderson as its new CEO on Wednesday, potentially ending a dramatic and difficult chapter during which its current chief executive, Werner Baumann, presided over the disastrous $63 billion purchase of the agriculture firm Monsanto. Anderson will take over April 1, becoming the first American to run the 160-year-old conglomerate, which invented aspirin and later played a major role in the development of hormonal contraceptives, hemophilia clotting factors,

114
114
article thumbnail

The Variants of COVID-19

Drug Topics

XBB, a less severe but more contagious strain of COVID-19, has taken over as the dominant Omicron strain.

461
461
article thumbnail

Bayer, Astellas switch CEOs amid major inflection points

PharmaVoice

Bayer’s Bill Anderson and Astellas’ Naoki Okamura will be charged with setting the companies on growth trajectories for 2023.

130
130
article thumbnail

Albertsons launches app uniting pharmacy, nutrition and telehealth

Fierce Healthcare

Albertsons launches app uniting pharmacy, nutrition and telehealth aburky Fri, 02/10/2023 - 16:29

116
116
article thumbnail

STAT+: Pharma loses a court battle in its bid to block states from importing drugs from Canada

STAT

In a setback to the pharmaceutical industry, a federal judge has tossed a lawsuit that sought to prevent state governments from importing medicines from Canada. The decision is likely to embolden more states to now consider the approach as they look to lower the cost of prescription drugs In a 26-page opinion , U.S. District Court Judge Timothy Kelly ruled that drug companies failed to prove they would face a “concrete risk of harm” from a federal rule that would allow states to im

114
114
article thumbnail

On the Precipice of the World’s First RSV Vaccine: What’s Taking So Long?

Drug Topics

RSV cases spiked to unprecedented levels this season. Why were these infections so frequent and severe, and why has vaccine development taken so long?

Vaccines 423
article thumbnail

The unique playbook of Biohaven’s CEO

PharmaVoice

Vlad Coric’s offbeat business strategy paid off once with a Pfizer buyout. Can he do it again?

130
130
article thumbnail

DOJ collected nearly $2B in health fraud False Claims Act cases in fiscal year 2022

Fierce Healthcare

DOJ collected nearly $2B in health fraud False Claims Act cases in fiscal year 2022 rking Wed, 02/08/2023 - 16:01

116
116
article thumbnail

NCPA endorses reintroduction of Senate FTC/PBM bills

Drug Store News

NCPA issued gratitude to Sens. Cantwell and Grassley for their efforts to "pull back the curtain on PBMs and push for FTC review of anticompetitive PBM practices.

106
106
article thumbnail

The 2023 Dermatology Drug Pipeline

Drug Topics

This year will be an exciting one for dermatologic therapy and pharmacology as treatments continue to evolve.

360
360
article thumbnail

Roche, Chiesi and the FDA change major leadership roles as they strive for growth in 2023

PharmaVoice

From Roche’s new pharma chief to the departure of the FDA’s gene therapy head, these moves are bound to shake up the industry.

FDA 130